Miras, who has received research funding from companies that manufacture weight-loss drugs, said they have been used to treat diabetes for about 20 years and their common side effects are already known, but added obesity is more common in the population
DOI: 10.1056/NEJMp2303120 Hoffman J (2023): Tranq Dope: Animal Sedative Mixed With Fentanyl Brings Fresh Horror to U.S
You push hard in the gym
Follow your SOP and the SDS for stability, container choice, and holding time
(PubMed) Balamurugan K, Vaziri ND, Said HM
The tweaks arrive ahead of the new year, when many consumers set personal fitness goals, and as the GLP-1 market is forecast to surpass $150 billion by 2030 on the back of momentum for blockbuster drugs like Ozempic, Zepbound and Wegovy